GovChime
Notice ID: b4a84d28aaab4be1871f612f736bc568Solicitation

Whole Genome DNA Methylation and Genotyping for SL

Archived on August 22, 2024. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
7:30 AM UTC−04:00
Posted
July 31, 2024
Notice type
Solicitation
NAICS
611310: Colleges, Universities, and Professional Schools
Agency
Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH

Notice details

Office
NATIONAL INSTITUTES OF HEALTH NHLBI
Last updated
Sep 9, 2025

Identifiers

Solicitation number
75N92024Q1066
Notice ID
b4a84d28aaab4be1871f612f736bc568

Description

Whole Genome DNA Methylation and Genotyping for SLE patients Third Phase

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Documents

No documents available.

Lifecycle

Solicitation:75N92024Q1066
  1. Solicitation

Award typically follows within 30–90 days after the response deadline. (estimate)

  1. SolicitationCurrentJul 31, 2024

    Whole Genome DNA Methylation and Genotyping for SL

    Notice b4a84d28aaab4be1871f612f736bc568 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline
(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitation will not be issued. (ii) The solicitation number is 75N98026Q01209/PCA-NIA-08501. This solicitation is issued as a Notice of Intent (NOI) for a non-competitive combined synopsis/solicitation to award a contract or purchase order without providing for full and open competition (including brand-name, if applicable). This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold. Additional authority includes 41 U.S.C. 1901 and FAR 6.302-3(a)(2)(ii). The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, intends to negotiate and award a firm fix-price award on a non-competitive basis to Epigenetic Clock Development Foundation 1124 W. Carson Street, MRL Bldg., 3rd Floor Torrance, CA 90502 US to provide obtain DNA methylation profiling and epigenetic age analysis for 320 previously extracted murine DNA samples using the Mammal320K methylation array and established Horvath epigenetic clock methodologies.
39%
Combined Synopsis09/23/2026
(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitation will not be issued. (ii) The solicitation number is 75N98026Q01212/PCA-NIA-08124. This solicitation is issued as a Notice of Intent (NOI) for a non-competitive combined synopsis/solicitation to award a contract or purchase order without providing for full and open competition (including brand-name, if applicable). This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold. Additional authority includes 41 U.S.C. 1901 and FAR 6.302-3(a)(2)(ii). The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, intends to negotiate and award a firm fix-price award on a non-competitive basis to Metabolon Inc. 617 Davis Drive, Suite 100, Morrisville, NC 27560 to assay global metabolomics data and short chain fatty acids (SCFA) via the Metabolon platform from 369 blood samples in the BLSA. These metabolomics data will be used to identify metabolomic signatures of anthropometric aging quantified via a 3D body scanner.
39%
Combined Synopsis09/23/2026
Whole Genome DNA Methylation and Genotyping for SLE patients, Third Phase
100%
AwardedOpen
Whole Genome DNA EPIC Methylation Profiling SLE
100%
AwardedOpen
DNA Methylation Profiling and Data Collection
76%
AwardedOpen

Additional Details

Solicitation Number

75N92024Q1066

Archive Date

Aug 22, 2024

Office Address

BETHESDA, MD, 20892